Page last updated: 2024-11-04

tegafur and Pyloric Stenosis

tegafur has been researched along with Pyloric Stenosis in 11 studies

Pyloric Stenosis: Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants.

Research Excerpts

ExcerptRelevanceReference
" He had nausea, vomiting and anorexia due to pyloric stenosis, and was treated with 600 mg of UFT E granules/day orally for 5 consecutive days followed by 2 drug-free days (weekly-5 method), and 2 mg of lentinan intravenously twice a week."7.70[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. ( Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T, 2000)
" He had nausea, vomiting and anorexia due to pyloric stenosis, and was treated with 600 mg of UFT E granules/day orally for 5 consecutive days followed by 2 drug-free days (weekly-5 method), and 2 mg of lentinan intravenously twice a week."3.70[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. ( Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T, 2000)
"A 72-year-old man with advanced gastric cancer was referred to our hospital."2.49[A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin]. ( Fujino, M; Hasegawa, A; Kametaka, H; Koyama, T; Makino, H; Matsuo, M; Seike, K; Yokoyama, M, 2013)
"We report a case of advanced gastric cancer with pyloric stenosis, in which a curative resection was performed following gastrojejunostomy and S-1 based chemotherapy."1.38[Distal gastrectomy for initially unresectable gastric cancer with pyloric stenosis following gastrojejunostomy and S-1 plus CDDP chemotherapy]. ( Kawai, T; Kinoshita, K; Kobayashi, S; Kusano, M; Miyagishima, T; Nagasako, Y; Ogasawara, K; Sunahara, M; Takahashi, M, 2012)
"We report a patient with an advanced gastric cancer complicated by pyloric stenosis who was effectively treated by S-1 mono-therapy after gastrojejunostomy."1.35[Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1]. ( Fujiwara, Y; Hayashi, C; Kobayashi, M; Koishi, K; Kojima, S; Matsumoto, T; Miwa, H; Sasako, M; Tanaka, J; Tomita, N; Yamamoto, N; Yamamura, T, 2009)
"We report a patient with unresectable gastric cancer who was effectively treated with S-1 after gastrojejunostomy."1.34[A case of unresectable gastric cancer complicated by serious pyloric stenosis in which S-1 administration after gastrojejunostomy proved effective]. ( Fujii, M; Hirota, M; Matsuda, C; Mikata, S; Morimoto, Y; Nishikawa, K; Tanaka, Y, 2007)
"At laparotomy to improve anemia and pyloric stenosis in September 2001, lymphnode metastases invaded the stomach and the pancreatic body."1.33[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006)
"He was diagnosed as having gastric cancer (L, post, Type 2, T2 (SS), N2, stage IIIA)."1.33[A case of a gastric cancer patient who obtained good treatment in spite of a nontreatment decision]. ( Ami, K; Andou, M; Ganno, H; Ito, T; Nagahama, T; Ohbu, M; Taira, M, 2006)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (63.64)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujino, M2
Kametaka, H1
Makino, H1
Yokoyama, M1
Matsuo, M1
Seike, K1
Koyama, T1
Hasegawa, A1
Michiura, T1
Miyazaki, S1
Fujita, S1
Hirose, H1
Miyazaki, Y1
Sugimoto, S1
Yamabe, K1
Nagaoka, M1
Nishikawa, K2
Iwase, K1
Fujii, M2
Matsuda, C2
Shimada, K1
Hirota, M2
Kimura, T1
Wada, D1
Nasu, S1
Tanaka, Y2
Matsumoto, T1
Fujiwara, Y1
Yamamoto, N1
Hayashi, C1
Koishi, K1
Kojima, S1
Tanaka, J1
Kobayashi, M1
Yamamura, T1
Miwa, H1
Tomita, N1
Sasako, M1
Matsushima, Y1
Kawabata, R1
Imamura, H1
Kishimoto, T1
Hachino, Y1
Yasui, Y1
Fujii, C1
Fukunaga, M1
Ohzato, H1
Furukawa, H1
Sunahara, M1
Kawai, T1
Nagasako, Y1
Kobayashi, S1
Takahashi, M1
Ogasawara, K1
Kusano, M1
Kinoshita, K1
Miyagishima, T1
Kobayashi, K1
Ueki, K1
Wakakuwa, R1
Ishizuka, D1
Tada, T1
Ohbu, M1
Taira, M1
Ganno, H1
Ami, K1
Nagahama, T1
Ito, T1
Andou, M1
Morimoto, Y1
Mikata, S1
Ishii, N1
Fujitani, S1
Suzuki, S1
Tsukamoto, M1
Arai, M1
Hashimoto, A1
Izuka, Y1
Fukuda, K1
Horiki, N1
Fujita, Y1
Takemura, T1
Takahashi, S1
Yoshikawa, T1
Kondo, M1

Reviews

1 review available for tegafur and Pyloric Stenosis

ArticleYear
[A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastric Bypass;

2013

Other Studies

10 other studies available for tegafur and Pyloric Stenosis

ArticleYear
[A case of advanced HER2- positive gastric cancer with a partial response to molecular targeted chemotherapy (S-1+CDDP+Trastuzumab)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug C

2014
[Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:4

    Topics: Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Case-Contr

2009
[Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combinations; Fatal Outcome;

2009
[Gastrojejunostomy followed by chemotherapy with S-1 in unresectable gastric cancer with pyloric stenosis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Com

2012
[Distal gastrectomy for initially unresectable gastric cancer with pyloric stenosis following gastrojejunostomy and S-1 plus CDDP chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati

2012
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:8

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb

2006
[A case of a gastric cancer patient who obtained good treatment in spite of a nontreatment decision].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:12

    Topics: Alcoholism; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Male; Middle Aged; Py

2006
[A case of unresectable gastric cancer complicated by serious pyloric stenosis in which S-1 administration after gastrojejunostomy proved effective].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Combined Modality

2007
[A case of advanced gastric cancer with pyloric stenosis and obstructive jaundice responding to s-1/paclitaxel combination therapy after endoscopic balloon dilatation and endoscopic biliary drainage].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Catheterization; Drug

2008
[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Len

2000